OXYBUTYNIN

OXYBUTYNIN was reported 29395 times

These side effects are most commonly reported by patients taking OXYBUTYNIN:

# Side effect Count
0 DRUG INEFFECTIVE 4005
1 FATIGUE 1585
2 FALL 1506
3 OFF LABEL USE 1309
4 NAUSEA 1255
5 DIZZINESS 1177
6 DIARRHOEA 1130
7 PAIN 1109
8 URINARY TRACT INFECTION 1077
9 HEADACHE 1019
10 PRURITUS 1018
11 APPLICATION SITE ERYTHEMA 932
12 ASTHENIA 918
13 PRODUCT ADHESION ISSUE 843
14 RASH 841
15 DYSPNOEA 773
16 CONSTIPATION 762
17 GAIT DISTURBANCE 732
18 MALAISE 730
19 VOMITING 713
20 DEATH 707
21 DRY MOUTH 697
22 ERYTHEMA 664
23 DRUG EFFECT DECREASED 635
24 PNEUMONIA 627
25 APPLICATION SITE PRURITUS 619
26 ARTHRALGIA 609
27 WEIGHT DECREASED 604
28 PAIN IN EXTREMITY 588
29 CONDITION AGGRAVATED 587
30 BACK PAIN 551
31 INSOMNIA 550
32 DEPRESSION 543
33 CHRONIC KIDNEY DISEASE 540
34 PRODUCT QUALITY ISSUE 522
35 ANXIETY 516
36 CONFUSIONAL STATE 502
37 PYREXIA 497
38 SOMNOLENCE 485
39 ACUTE KIDNEY INJURY 476
40 BALANCE DISORDER 458
41 FEELING ABNORMAL 438
42 RENAL FAILURE 433
43 MEMORY IMPAIRMENT 432
44 COUGH 424
45 ABDOMINAL PAIN 423
46 MUSCLE SPASMS 419
47 PRODUCT USE ISSUE 409
48 MULTIPLE SCLEROSIS RELAPSE 405
49 MUSCULAR WEAKNESS 404
50 PRODUCT DOSE OMISSION ISSUE 393
51 DECREASED APPETITE 382
52 HYPERTENSION 378
53 HYPOAESTHESIA 374
54 PERIPHERAL SWELLING 367
55 POLLAKIURIA 354
56 APPLICATION SITE RASH 351
57 URINARY INCONTINENCE 351
58 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 347
59 ALOPECIA 346
60 HYPOTENSION 346
61 TREMOR 339
62 ABDOMINAL PAIN UPPER 336
63 ANAEMIA 335
64 WEIGHT INCREASED 333
65 CHEST PAIN 332
66 DRUG INTERACTION 332
67 VISION BLURRED 329
68 PARAESTHESIA 320
69 COVID-19 315
70 DEHYDRATION 301
71 DRUG HYPERSENSITIVITY 293
72 DRUG DOSE OMISSION 289
73 BLOOD PRESSURE INCREASED 287
74 HYPERSENSITIVITY 280
75 ABDOMINAL DISCOMFORT 277
76 MULTIPLE SCLEROSIS 274
77 CONTUSION 272
78 MOBILITY DECREASED 272
79 INFECTION 266
80 NASOPHARYNGITIS 259
81 CEREBROVASCULAR ACCIDENT 258
82 APPLICATION SITE PAIN 257
83 VISUAL IMPAIRMENT 251
84 DYSPHAGIA 250
85 SEPSIS 249
86 HALLUCINATION 248
87 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 246
88 URINARY RETENTION 244
89 DYSPEPSIA 240
90 OEDEMA PERIPHERAL 239
91 BURNING SENSATION 234
92 MYALGIA 232
93 LOSS OF CONSCIOUSNESS 229
94 TOXICITY TO VARIOUS AGENTS 228
95 SYNCOPE 225
96 GASTROOESOPHAGEAL REFLUX DISEASE 224
97 INCORRECT DOSE ADMINISTERED 223
98 SKIN IRRITATION 221
99 PRODUCT USE IN UNAPPROVED INDICATION 219
100 THERAPY CESSATION 217
101 INJECTION SITE PAIN 213
102 ATRIAL FIBRILLATION 211
103 FLUSHING 211
104 WHITE BLOOD CELL COUNT DECREASED 210
105 APPLICATION SITE IRRITATION 206
106 COMPLETED SUICIDE 206
107 HOSPITALISATION 206
108 DYSURIA 205
109 URTICARIA 204
110 ARTHRITIS 203
111 CHILLS 203
112 HOT FLUSH 203
113 INFLUENZA 202
114 CYSTITIS 201
115 MUSCULOSKELETAL STIFFNESS 201
116 DRUG ADMINISTERED AT INAPPROPRIATE SITE 192
117 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 190
118 BLOOD GLUCOSE INCREASED 187
119 JOINT SWELLING 185
120 RASH ERYTHEMATOUS 183
121 NEPHROLITHIASIS 181
122 HAEMOGLOBIN DECREASED 180
123 NEUROPATHY PERIPHERAL 180
124 AMNESIA 178
125 BRONCHITIS 177
126 SEIZURE 174
127 OVERDOSE 173
128 SINUSITIS 170
129 OROPHARYNGEAL PAIN 169
130 ABDOMINAL DISTENSION 167
131 HYPERHIDROSIS 167
132 MYOCARDIAL INFARCTION 166
133 CHEST DISCOMFORT 162
134 ASTHMA 161
135 PRODUCT DOSE OMISSION 160
136 GASTROINTESTINAL HAEMORRHAGE 159
137 RASH PRURITIC 159
138 MIGRAINE 157
139 DRY SKIN 154
140 INTENTIONAL PRODUCT MISUSE 153
141 OSTEOARTHRITIS 152
142 RHEUMATOID ARTHRITIS 152
143 PALPITATIONS 151
144 DELIRIUM 150
145 SWELLING 148
146 UNEVALUABLE EVENT 145
147 INCORRECT DRUG ADMINISTRATION DURATION 143
148 STRESS 141
149 CARDIAC FAILURE CONGESTIVE 140
150 COGNITIVE DISORDER 140
151 DISCOMFORT 139
152 DRUG EFFECT INCOMPLETE 138
153 THROMBOSIS 136
154 SPEECH DISORDER 134
155 HAEMATOCHEZIA 133
156 MICTURITION URGENCY 133
157 THERAPY INTERRUPTED 133
158 VERTIGO 133
159 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 132
160 PULMONARY EMBOLISM 132
161 CATARACT 131
162 OXYGEN SATURATION DECREASED 131
163 INFLUENZA LIKE ILLNESS 130
164 HEART RATE INCREASED 129
165 SLEEP DISORDER 129
166 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 128
167 END STAGE RENAL DISEASE 127
168 GENERAL PHYSICAL HEALTH DETERIORATION 127
169 HERPES ZOSTER 127
170 INFUSION RELATED REACTION 127
171 LETHARGY 127
172 PSORIASIS 127
173 CELLULITIS 126
174 DRY EYE 125
175 DYSARTHRIA 125
176 RENAL INJURY 125
177 DRUG INTOLERANCE 124
178 PLATELET COUNT DECREASED 124
179 TACHYCARDIA 124
180 AGITATION 123
181 BLISTER 123
182 EPISTAXIS 123
183 THERAPEUTIC RESPONSE UNEXPECTED 122
184 EMOTIONAL DISTRESS 121
185 WRONG TECHNIQUE IN DRUG USAGE PROCESS 121
186 ADVERSE DRUG REACTION 119
187 EXPIRED PRODUCT ADMINISTERED 119
188 CARDIAC DISORDER 118
189 ILLNESS 118
190 TREATMENT FAILURE 118
191 NOCTURIA 117
192 BLADDER DISORDER 116
193 DYSPHONIA 116
194 RECTAL HAEMORRHAGE 116
195 DISEASE PROGRESSION 115
196 ADVERSE EVENT 114
197 BLOOD PRESSURE DECREASED 114
198 SKIN DISCOLOURATION 114
199 DYSSTASIA 112
200 INTENTIONAL PRODUCT USE ISSUE 112
201 FEELING HOT 110
202 FLATULENCE 110
203 MENTAL STATUS CHANGES 108
204 HIP FRACTURE 106
205 PRODUCT PACKAGING ISSUE 106
206 INCONTINENCE 105
207 RENAL IMPAIRMENT 105
208 NECK PAIN 104
209 DISTURBANCE IN ATTENTION 103
210 GASTROINTESTINAL DISORDER 103
211 INJECTION SITE ERYTHEMA 103
212 DIABETES MELLITUS 102
213 HYPERTONIC BLADDER 102
214 NEUTROPENIA 102
215 DISORIENTATION 101
216 OSTEOPOROSIS 101
217 GAIT INABILITY 100
218 APPLICATION SITE BURN 99
219 HEAD INJURY 99
220 CARDIAC ARREST 98
221 DYSGEUSIA 98
222 DYSKINESIA 98
223 HALLUCINATION, VISUAL 98
224 HYPONATRAEMIA 98
225 MUSCLE SPASTICITY 98
226 RESPIRATORY FAILURE 98
227 ARTHROPATHY 97
228 LIMB DISCOMFORT 97
229 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 97
230 NERVOUSNESS 97
231 ROAD TRAFFIC ACCIDENT 97
232 BRADYCARDIA 96
233 DEEP VEIN THROMBOSIS 96
234 CONVULSION 94
235 HEART RATE DECREASED 94
236 SUICIDAL IDEATION 94
237 DEMENTIA 93
238 DEPRESSED MOOD 91
239 FLUID RETENTION 91
240 HAEMATURIA 91
241 KIDNEY INFECTION 91
242 COLITIS 89
243 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 89
244 SKIN EXFOLIATION 89
245 BLOOD CREATININE INCREASED 88
246 NEPHROGENIC ANAEMIA 88
247 SKIN BURNING SENSATION 88
248 SWELLING FACE 88
249 HYPOKALAEMIA 87
250 BONE PAIN 86
251 HAEMORRHAGE 86
252 STOMATITIS 86
253 DEVICE ISSUE 85
254 NASAL CONGESTION 85
255 CARDIAC FAILURE 84
256 INJURY 84
257 PLEURAL EFFUSION 84
258 SLEEP APNOEA SYNDROME 84
259 UNDERDOSE 84
260 BLOOD URINE PRESENT 83
261 HYPOGLYCAEMIA 83
262 INFLAMMATION 83
263 UPPER RESPIRATORY TRACT INFECTION 83
264 DYSPNOEA EXERTIONAL 82
265 MACULAR DEGENERATION 82
266 MOVEMENT DISORDER 82
267 APPLICATION SITE DISCOLOURATION 81
268 INTERVERTEBRAL DISC PROTRUSION 81
269 RHINORRHOEA 81
270 SURGERY 81
271 THROAT IRRITATION 81
272 UNRESPONSIVE TO STIMULI 81
273 BLOOD POTASSIUM DECREASED 80
274 BLOOD PRESSURE FLUCTUATION 79
275 CHROMATURIA 79
276 HEPATIC ENZYME INCREASED 79
277 LABORATORY TEST ABNORMAL 79
278 MUSCULOSKELETAL PAIN 79
279 INTESTINAL OBSTRUCTION 78
280 NO ADVERSE EVENT 78
281 ORAL CANDIDIASIS 78
282 BLOOD CHOLESTEROL INCREASED 77
283 ILL-DEFINED DISORDER 77
284 DRUG EFFECT DELAYED 76
285 FREQUENT BOWEL MOVEMENTS 76
286 NEURALGIA 76
287 PRODUCTIVE COUGH 76
288 HYPERKALAEMIA 75
289 HYPERSOMNIA 75
290 MENTAL DISORDER 75
291 RED BLOOD CELL COUNT DECREASED 75
292 RENAL DISORDER 75
293 ENCEPHALOPATHY 74
294 OEDEMA 74
295 COLITIS ULCERATIVE 73
296 INJECTION SITE REACTION 73
297 PRODUCT SUBSTITUTION ISSUE 73
298 RASH MACULAR 73
299 ANHEDONIA 72
300 ANTICHOLINERGIC SYNDROME 72
301 LIP SWELLING 72
302 TREATMENT NONCOMPLIANCE 72
303 ABASIA 71
304 PRODUCT CLOSURE REMOVAL DIFFICULT 71
305 RESPIRATORY ARREST 71
306 DERMATITIS CONTACT 70
307 HYPOACUSIS 70
308 PARAESTHESIA ORAL 70
309 PSYCHOTIC DISORDER 69
310 RENAL FAILURE ACUTE 69
311 ABNORMAL BEHAVIOUR 68
312 FUNGAL INFECTION 68
313 LOWER RESPIRATORY TRACT INFECTION 68
314 THERAPEUTIC RESPONSE DECREASED 68
315 TINNITUS 68
316 LUNG DISORDER 67
317 THROMBOCYTOPENIA 67
318 EYE PAIN 66
319 FEBRILE NEUTROPENIA 66
320 TRANSIENT ISCHAEMIC ATTACK 66
321 CROHN^S DISEASE 65
322 LIMB INJURY 65
323 SWOLLEN TONGUE 65
324 WHEEZING 65
325 WHITE BLOOD CELL COUNT INCREASED 65
326 HAEMATOCRIT DECREASED 64
327 PNEUMONIA ASPIRATION 64
328 UPPER LIMB FRACTURE 64
329 ANKLE FRACTURE 63
330 DEPRESSED LEVEL OF CONSCIOUSNESS 63
331 PROCEDURAL PAIN 63
332 EYE DISORDER 62
333 PARKINSON^S DISEASE 62
334 IMPAIRED GASTRIC EMPTYING 61
335 INJECTION SITE BRUISING 61
336 INJECTION SITE PRURITUS 61
337 LYMPHOCYTE COUNT DECREASED 61
338 MALIGNANT NEOPLASM PROGRESSION 61
339 PULMONARY OEDEMA 61
340 URINE ODOUR ABNORMAL 61
341 CHOLELITHIASIS 60
342 INJECTION SITE HAEMORRHAGE 60
343 NEOPLASM MALIGNANT 60
344 PANCYTOPENIA 60
345 RADICULOPATHY 60
346 ALANINE AMINOTRANSFERASE INCREASED 59
347 BLADDER SPASM 59
348 DIPLOPIA 59
349 PRODUCT DOSE OMISSION IN ERROR 59
350 STAPHYLOCOCCAL INFECTION 59
351 TOOTH DISORDER 59
352 WITHDRAWAL SYNDROME 59
353 GASTRIC DISORDER 58
354 HYPOTHYROIDISM 58
355 THERAPEUTIC PRODUCT EFFECT DECREASED 58
356 AGGRESSION 57
357 CARDIO-RESPIRATORY ARREST 57
358 DRUG ADMINISTRATION ERROR 57
359 EAR PAIN 57
360 EYE IRRITATION 57
361 NIGHTMARE 57
362 RESTLESS LEGS SYNDROME 57
363 RESTLESSNESS 57
364 SINUS DISORDER 57
365 TUBULOINTERSTITIAL NEPHRITIS 56
366 BLINDNESS 55
367 BLOOD GLUCOSE DECREASED 55
368 DEVICE MALFUNCTION 55
369 ELECTROCARDIOGRAM QT PROLONGED 55
370 IRRITABILITY 55
371 JOINT INJURY 55
372 ORAL PAIN 55
373 RENAL TUBULAR NECROSIS 55
374 SEDATION 55
375 APHASIA 54
376 CENTRAL NERVOUS SYSTEM LESION 54
377 FOOT FRACTURE 54
378 HYPOXIA 54
379 INTENTIONAL OVERDOSE 54
380 MEDICATION ERROR 54
381 MUSCULOSKELETAL DISORDER 54
382 PANIC ATTACK 54
383 ANGINA PECTORIS 53
384 ASPARTATE AMINOTRANSFERASE INCREASED 53
385 BODY HEIGHT DECREASED 53
386 CLOSTRIDIUM DIFFICILE INFECTION 53
387 DIVERTICULITIS 53
388 ECONOMIC PROBLEM 53
389 HYPOPHAGIA 53
390 RIB FRACTURE 53
391 VAGINAL DISCHARGE 53
392 WOUND 53
393 ATAXIA 52
394 EATING DISORDER 52
395 GASTRITIS 52
396 INJECTION SITE SWELLING 52
397 IRRITABLE BOWEL SYNDROME 52
398 LIVER FUNCTION TEST ABNORMAL 52
399 UROSEPSIS 52
400 BREAST CANCER 51
401 CORONARY ARTERY DISEASE 51
402 PROCTITIS 51
403 PSORIATIC ARTHROPATHY 51
404 THERAPY NON-RESPONDER 51
405 APPLICATION SITE VESICLES 50
406 BLOOD PRESSURE SYSTOLIC INCREASED 50
407 BLOOD SODIUM DECREASED 50
408 FEELING COLD 50
409 FEMALE GENITAL TRACT FISTULA 50
410 FEMUR FRACTURE 50
411 FIBROMYALGIA 50
412 INTERNATIONAL NORMALISED RATIO INCREASED 50
413 PAIN IN JAW 50
414 ROTATOR CUFF SYNDROME 50
415 VAGINAL FLATULENCE 50
416 ABNORMAL DREAMS 49
417 DECUBITUS ULCER 49
418 IMPAIRED HEALING 49
419 MENTAL IMPAIRMENT 49
420 ACNE 48
421 ACUTE RESPIRATORY FAILURE 48
422 HEMIPARESIS 48
423 PARANOIA 48
424 POOR QUALITY SLEEP 48
425 PRURITUS GENERALISED 48
426 CRYING 47
427 KNEE ARTHROPLASTY 47
428 LACERATION 47
429 LOWER LIMB FRACTURE 47
430 ORTHOSTATIC HYPOTENSION 47
431 CHRONIC SINUSITIS 46
432 DISEASE RECURRENCE 46
433 LOCALISED INFECTION 46
434 MUSCLE TIGHTNESS 46
435 OSTEOMYELITIS 46
436 PRODUCT PHYSICAL ISSUE 46
437 VIRAL INFECTION 46
438 WALKING AID USER 46
439 WRIST FRACTURE 46
440 ANAPHYLACTIC REACTION 45
441 BIPOLAR DISORDER 45
442 COMA 45
443 MATERNAL EXPOSURE DURING PREGNANCY 45
444 NERVOUS SYSTEM DISORDER 45
445 THIRST 45
446 ANGIOEDEMA 44
447 APHONIA 44
448 BLADDER PAIN 44
449 INJECTION SITE MASS 44
450 OCULAR HYPERAEMIA 44
451 OSTEOPENIA 44
452 PRESCRIBED UNDERDOSE 44
453 SCIATICA 44
454 SKIN DISORDER 44
455 UPPER GASTROINTESTINAL HAEMORRHAGE 44
456 ACCIDENTAL OVERDOSE 43
457 APPLICATION SITE DISCOMFORT 43
458 BONE DISORDER 43
459 CHOKING 43
460 HAEMATEMESIS 43
461 HAEMORRHOIDS 43
462 MUSCULOSKELETAL DISCOMFORT 43
463 SCAR 43
464 SPINAL OSTEOARTHRITIS 43
465 ANAL INCONTINENCE 42
466 COORDINATION ABNORMAL 42
467 HAEMOPTYSIS 42
468 HYPOKINESIA 42
469 INTENTIONAL DOSE OMISSION 42
470 MUCOSAL INFLAMMATION 42
471 NEUROGENIC BLADDER 42
472 TEMPERATURE INTOLERANCE 42
473 URINE ABNORMALITY 42
474 APPLICATION SITE SWELLING 41
475 BLOOD CREATINE PHOSPHOKINASE INCREASED 41
476 DELUSION 41
477 DRUG DEPENDENCE 41
478 FEAR 41
479 HYPERPARATHYROIDISM SECONDARY 41
480 LIGAMENT SPRAIN 41
481 NIGHT SWEATS 41
482 POST PROCEDURAL COMPLICATION 41
483 PRESYNCOPE 41
484 SKIN LESION 41
485 SKIN REACTION 41
486 SKIN ULCER 41
487 BACK DISORDER 40
488 CEREBRAL HAEMORRHAGE 40
489 DRUG PRESCRIBING ERROR 40
490 FEEDING DISORDER 40
491 GLOMERULAR FILTRATION RATE DECREASED 40
492 GLOSSODYNIA 40
493 HIATUS HERNIA 40
494 MIDDLE INSOMNIA 40
495 POOR VENOUS ACCESS 40
496 REBOUND ACID HYPERSECRETION 40
497 TARDIVE DYSKINESIA 40
498 THROAT TIGHTNESS 40
499 URINE ANALYSIS ABNORMAL 40
500 VISUAL ACUITY REDUCED 40
501 VITAMIN D DEFICIENCY 40
502 BLOOD PRESSURE ABNORMAL 39
503 DRY THROAT 39
504 EAR INFECTION 39
505 EYE SWELLING 39
506 HEART RATE IRREGULAR 39
507 JOINT STIFFNESS 39
508 LEUKOPENIA 39
509 PERONEAL NERVE PALSY 39
510 PRE-EXISTING CONDITION IMPROVED 39
511 SPINAL FRACTURE 39
512 SUICIDE ATTEMPT 39
513 DRUG WITHDRAWAL SYNDROME 38
514 FOETAL EXPOSURE DURING PREGNANCY 38
515 GASTROENTERITIS 38
516 HAEMATOMA 38
517 LUNG NEOPLASM MALIGNANT 38
518 MUSCLE TWITCHING 38
519 RASH PAPULAR 38
520 RESPIRATORY TRACT INFECTION 38
521 SALIVARY HYPERSECRETION 38
522 SEPTIC SHOCK 38
523 TOOTHACHE 38
524 VAGINAL HAEMORRHAGE 38
525 ABDOMINAL PAIN LOWER 37
526 BLOOD UREA INCREASED 37
527 CARPAL TUNNEL SYNDROME 37
528 EMOTIONAL DISORDER 37
529 ERUCTATION 37
530 EXTRAPYRAMIDAL DISORDER 37
531 FEELING JITTERY 37
532 GLYCOSYLATED HAEMOGLOBIN INCREASED 37
533 LYMPHADENOPATHY 37
534 PULMONARY MASS 37
535 SENSORY DISTURBANCE 37
536 THERAPEUTIC RESPONSE SHORTENED 37
537 ACTIVITIES OF DAILY LIVING IMPAIRED 36
538 ANGER 36
539 ARRHYTHMIA 36
540 DRUG ABUSE 36
541 EPILEPSY 36
542 FRACTURE 36
543 HALLUCINATION, AUDITORY 36
544 JAUNDICE 36
545 MACULOPATHY 36
546 MOOD ALTERED 36
547 MUSCULOSKELETAL CHEST PAIN 36
548 PERIPHERAL COLDNESS 36
549 PROSTATE CANCER 36
550 THYROID DISORDER 36
551 BODY TEMPERATURE INCREASED 35
552 DEVICE DISLOCATION 35
553 ECZEMA 35
554 HAIR TEXTURE ABNORMAL 35
555 HIP ARTHROPLASTY 35
556 LOCAL SWELLING 35
557 LYMPHOPENIA 35
558 MOTOR DYSFUNCTION 35
559 PARKINSONISM 35
560 PLASMA CELL MYELOMA 35
561 PRODUCT STORAGE ERROR 35
562 PSYCHOMOTOR HYPERACTIVITY 35
563 RASH GENERALISED 35
564 RETCHING 35
565 APPLICATION SITE REACTION 34
566 BACTERIAL INFECTION 34
567 BLOOD ALKALINE PHOSPHATASE INCREASED 34
568 BLOOD GLUCOSE ABNORMAL 34
569 BLOOD IRON DECREASED 34
570 DEAFNESS 34
571 DENTAL CARIES 34
572 EXTRA DOSE ADMINISTERED 34
573 FULL BLOOD COUNT DECREASED 34
574 HOSPICE CARE 34
575 INTERVERTEBRAL DISC DEGENERATION 34
576 NEUTROPHIL COUNT DECREASED 34
577 PRODUCT USE COMPLAINT 34
578 TASTE DISORDER 34
579 TOOTH FRACTURE 34
580 ACUTE MYOCARDIAL INFARCTION 33
581 DISABILITY 33
582 FAECES DISCOLOURED 33
583 HEAD DISCOMFORT 33
584 HERNIA 33
585 INITIAL INSOMNIA 33
586 SKIN CANCER 33
587 AGEUSIA 32
588 EXOSTOSIS 32
589 EYE PRURITUS 32
590 FLANK PAIN 32
591 HYDRONEPHROSIS 32
592 IMPAIRED QUALITY OF LIFE 32
593 LEUKOCYTOSIS 32
594 MOUTH ULCERATION 32
595 PANCREATITIS 32
596 PARALYSIS 32
597 PROSTATIC SPECIFIC ANTIGEN INCREASED 32
598 SPINAL OPERATION 32
599 WHEELCHAIR USER 32
600 APPLICATION SITE WARMTH 31
601 BASAL CELL CARCINOMA 31
602 CANDIDA INFECTION 31
603 HYPOAESTHESIA ORAL 31
604 PULMONARY HYPERTENSION 31
605 RESPIRATORY DISORDER 31
606 ACCIDENT 30
607 APPLICATION SITE EXFOLIATION 30
608 APPLICATION SITE PAPULES 30
609 BLOOD POTASSIUM INCREASED 30
610 C-REACTIVE PROTEIN INCREASED 30
611 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 30
612 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30
613 CLOSTRIDIUM DIFFICILE COLITIS 30
614 CORONARY ARTERY OCCLUSION 30
615 GOUT 30
616 HEPATIC STEATOSIS 30
617 LIVER FUNCTION TEST INCREASED 30
618 LIVER INJURY 30
619 MOOD SWINGS 30
620 PAIN OF SKIN 30
621 PRESCRIBED OVERDOSE 30
622 RESPIRATORY TRACT CONGESTION 30
623 SMALL INTESTINAL OBSTRUCTION 30
624 TENDONITIS 30
625 TOOTH LOSS 30
626 DEVICE BREAKAGE 29
627 DIVERTICULUM 29
628 DIZZINESS POSTURAL 29
629 GASTRIC ULCER 29
630 GENERALISED TONIC-CLONIC SEIZURE 29
631 HYPERGLYCAEMIA 29
632 IMPAIRED DRIVING ABILITY 29
633 INCREASED APPETITE 29
634 LARYNGITIS 29
635 LOWER GASTROINTESTINAL HAEMORRHAGE 29
636 MEDICATION RESIDUE PRESENT 29
637 PULMONARY FIBROSIS 29
638 SINUS CONGESTION 29
639 SUBDURAL HAEMATOMA 29
640 TOOTH ABSCESS 29
641 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29
642 ALTERED STATE OF CONSCIOUSNESS 28
643 BLOOD MAGNESIUM DECREASED 28
644 BONE DENSITY DECREASED 28
645 BURSITIS 28
646 CONCUSSION 28
647 GASTROENTERITIS VIRAL 28
648 GLAUCOMA 28
649 PRODUCT AVAILABILITY ISSUE 28
650 PRODUCT PACKAGING QUANTITY ISSUE 28
651 PRODUCT PRESCRIBING ERROR 28
652 RENAL CYST 28
653 RHABDOMYOLYSIS 28
654 SARS-COV-2 TEST POSITIVE 28
655 SKIN LACERATION 28
656 TYPE 2 DIABETES MELLITUS 28
657 URINARY TRACT DISORDER 28
658 APPLICATION SITE INFLAMMATION 27
659 BEDRIDDEN 27
660 BLOOD TRIGLYCERIDES INCREASED 27
661 CEREBRAL INFARCTION 27
662 CYST 27
663 ERECTILE DYSFUNCTION 27
664 ESCHERICHIA URINARY TRACT INFECTION 27
665 FAECAL INCONTINENCE 27
666 FAECALOMA 27
667 HAND FRACTURE 27
668 INCOHERENT 27
669 INSURANCE ISSUE 27
670 JOINT DISLOCATION 27
671 MELAENA 27
672 MUSCLE RIGIDITY 27
673 NEEDLE ISSUE 27
674 NEUTROPHIL COUNT INCREASED 27
675 PRODUCT ADMINISTRATION INTERRUPTED 27
676 PSYCHOLOGICAL TRAUMA 27
677 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 27
678 SKIN ABRASION 27
679 APPLICATION SITE URTICARIA 26
680 ASPIRATION 26
681 BACK INJURY 26
682 HYPOMAGNESAEMIA 26
683 HYSTERECTOMY 26
684 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 26
685 LIVER DISORDER 26
686 MASS 26
687 MITRAL VALVE INCOMPETENCE 26
688 MUSCLE ATROPHY 26
689 NASAL DRYNESS 26
690 PHARYNGEAL SWELLING 26
691 TENDON DISORDER 26
692 URINARY TRACT INFECTION BACTERIAL 26
693 ACCIDENTAL EXPOSURE TO PRODUCT 25
694 BENIGN PROSTATIC HYPERPLASIA 25
695 COVID-19 PNEUMONIA 25
696 DERMATITIS ATOPIC 25
697 DIABETES MELLITUS INADEQUATE CONTROL 25
698 DYSTONIA 25
699 ENURESIS 25
700 HAIR COLOUR CHANGES 25
701 HYPERLIPIDAEMIA 25
702 RESPIRATORY DISTRESS 25
703 SEASONAL ALLERGY 25
704 SNEEZING 25
705 SPINAL COMPRESSION FRACTURE 25
706 SPINAL PAIN 25
707 ULCER 25
708 WHITE BLOOD CELLS URINE POSITIVE 25
709 CARDIOMYOPATHY 24
710 FACIAL PARALYSIS 24
711 FOOT DEFORMITY 24
712 GALLBLADDER DISORDER 24
713 LACRIMATION INCREASED 24
714 MYOCARDITIS 24
715 OESOPHAGITIS 24
716 ORAL HERPES 24
717 PERICARDIAL EFFUSION 24
718 RENAL PAIN 24
719 SCHIZOPHRENIA 24
720 SINUS TACHYCARDIA 24
721 SKIN FISSURES 24
722 THINKING ABNORMAL 24
723 ABSCESS 23
724 APLASTIC ANAEMIA 23
725 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23
726 ILEUS 23
727 IMMUNODEFICIENCY 23
728 INCORRECT PRODUCT ADMINISTRATION DURATION 23
729 LIP DRY 23
730 PELVIC PAIN 23
731 PRODUCT DISPENSING ERROR 23
732 PRODUCT RESIDUE PRESENT 23
733 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23
734 PYELONEPHRITIS 23
735 SKIN HAEMORRHAGE 23
736 SUSPECTED SUICIDE 23
737 TOOTH INFECTION 23
738 ATRIAL FLUTTER 22
739 BLOOD CALCIUM DECREASED 22
740 BLOOD TEST ABNORMAL 22
741 BODY TEMPERATURE DECREASED 22
742 CATATONIA 22
743 CHOLECYSTECTOMY 22
744 CONTRAINDICATED PRODUCT ADMINISTERED 22
745 CYSTITIS INTERSTITIAL 22
746 DRUG LEVEL INCREASED 22
747 DRUG WITHDRAWAL SYNDROME NEONATAL 22
748 DYSGRAPHIA 22
749 EXPOSURE DURING PREGNANCY 22
750 GINGIVAL BLEEDING 22
751 GRAND MAL CONVULSION 22
752 HEPATIC ENZYME ABNORMAL 22
753 HEPATIC FAILURE 22
754 HYPOVOLAEMIA 22
755 NEPHROPATHY 22
756 NYSTAGMUS 22
757 OBESITY 22
758 ONYCHOCLASIS 22
759 OSTEONECROSIS 22
760 PANCREATITIS ACUTE 22
761 PHARMACEUTICAL PRODUCT COMPLAINT 22
762 PHARYNGEAL OEDEMA 22
763 PHOTOPHOBIA 22
764 PLATELET COUNT INCREASED 22
765 PNEUMONITIS 22
766 SCAB 22
767 SINUS BRADYCARDIA 22
768 SOMNAMBULISM 22
769 TRIGEMINAL NEURALGIA 22
770 VAGINAL INFECTION 22
771 ANAPHYLACTIC SHOCK 21
772 CEREBRAL ATROPHY 21
773 CULTURE URINE POSITIVE 21
774 DECREASED INTEREST 21
775 DERMATITIS 21
776 EMPHYSEMA 21
777 ESCHERICHIA INFECTION 21
778 ESSENTIAL HYPERTENSION 21
779 FREEZING PHENOMENON 21
780 HYPOCALCAEMIA 21
781 IMPAIRED WORK ABILITY 21
782 INJECTION SITE EXTRAVASATION 21
783 INJECTION SITE RASH 21
784 INTERNAL HAEMORRHAGE 21
785 IRON DEFICIENCY ANAEMIA 21
786 ISCHAEMIC STROKE 21
787 METASTASES TO LIVER 21
788 MICTURITION DISORDER 21
789 MYASTHENIA GRAVIS 21
790 NERVE INJURY 21
791 POST PROCEDURAL INFECTION 21
792 PRODUCT ADMINISTRATION ERROR 21
793 SCOLIOSIS 21
794 SCRATCH 21
795 SPINAL DISORDER 21
796 STATUS EPILEPTICUS 21
797 THERMAL BURN 21
798 URINE OUTPUT DECREASED 21
799 ABNORMAL LOSS OF WEIGHT 20
800 APPLICATION SITE EROSION 20
801 ATRIOVENTRICULAR BLOCK FIRST DEGREE 20
802 BLINDNESS UNILATERAL 20
803 BRADYKINESIA 20
804 BRAIN FOG 20
805 CARDIOMEGALY 20
806 DEVICE LEAKAGE 20
807 DEVICE RELATED INFECTION 20
808 ELECTROLYTE IMBALANCE 20
809 HEMIPLEGIA 20
810 HUNGER 20
811 HYPERTHYROIDISM 20
812 INABILITY TO AFFORD MEDICATION 20
813 INTENTIONAL DRUG MISUSE 20
814 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20
815 MULTIPLE FRACTURES 20
816 NERVE COMPRESSION 20
817 ODYNOPHAGIA 20
818 OSTEONECROSIS OF JAW 20
819 PNEUMOTHORAX 20
820 PULMONARY CONGESTION 20
821 TENDERNESS 20
822 TONGUE DISCOLOURATION 20
823 TRICUSPID VALVE INCOMPETENCE 20
824 TRISMUS 20
825 URINE LEUKOCYTE ESTERASE POSITIVE 20
826 VITREOUS FLOATERS 20
827 APPLICATION SITE BRUISE 19
828 ARTERIOSCLEROSIS 19
829 BLADDER CANCER 19
830 BLOOD BILIRUBIN INCREASED 19
831 CARDIOVASCULAR DISORDER 19
832 COAGULOPATHY 19
833 DECREASED ACTIVITY 19
834 DERMATITIS ALLERGIC 19
835 EYE HAEMORRHAGE 19
836 GASTROINTESTINAL INFECTION 19
837 ILEUS PARALYTIC 19
838 INJECTION SITE URTICARIA 19
839 MADAROSIS 19
840 MALIGNANT MELANOMA 19
841 MUSCLE STRAIN 19
842 ORAL DISCOMFORT 19
843 PALLOR 19
844 PELVIC FRACTURE 19
845 PHARYNGITIS 19
846 POLYP 19
847 QUALITY OF LIFE DECREASED 19
848 SEROTONIN SYNDROME 19
849 SKIN WARM 19
850 SPINAL STENOSIS 19
851 TOOTH EXTRACTION 19
852 VULVOVAGINAL MYCOTIC INFECTION 19
853 VULVOVAGINAL PAIN 19
854 WEIGHT FLUCTUATION 19
855 ARTERIOSCLEROSIS CORONARY ARTERY 18
856 ATELECTASIS 18
857 BLOOD PRESSURE SYSTOLIC ABNORMAL 18
858 BLOOD PRESSURE SYSTOLIC DECREASED 18
859 BOWEL MOVEMENT IRREGULARITY 18
860 BRONCHOSPASM 18
861 COLD SWEAT 18
862 COLITIS ISCHAEMIC 18
863 DRUG DOSE OMISSION BY DEVICE 18
864 DRUG EFFECT VARIABLE 18
865 DRUG TOXICITY 18
866 FRUSTRATION TOLERANCE DECREASED 18
867 GOITRE 18
868 GROIN PAIN 18
869 HALLUCINATIONS, MIXED 18
870 HYPERAESTHESIA 18
871 INCORRECT ROUTE OF DRUG ADMINISTRATION 18
872 INFUSION SITE ERYTHEMA 18
873 INTENTIONAL SELF-INJURY 18
874 LYMPHOCYTE PERCENTAGE DECREASED 18
875 MALNUTRITION 18
876 METABOLIC ACIDOSIS 18
877 MOUTH SWELLING 18
878 MYOCLONUS 18
879 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18
880 PERIPHERAL VASCULAR DISORDER 18
881 RED BLOOD CELLS URINE POSITIVE 18
882 SENSORY LOSS 18
883 SLUGGISHNESS 18
884 TIBIA FRACTURE 18
885 TONGUE ULCERATION 18
886 VENTRICULAR EXTRASYSTOLES 18
887 VULVOVAGINAL DISCOMFORT 18
888 ADVERSE REACTION 17
889 APPLICATION SITE DRYNESS 17
890 BACTERAEMIA 17
891 BLOOD CREATINE INCREASED 17
892 BLOOD PRESSURE DIASTOLIC INCREASED 17
893 CHOLECYSTITIS 17
894 CHOLESTASIS 17
895 CIRCULATORY COLLAPSE 17
896 DEVICE OCCLUSION 17
897 DRY AGE-RELATED MACULAR DEGENERATION 17
898 FLUID OVERLOAD 17
899 FUNCTIONAL GASTROINTESTINAL DISORDER 17
900 FURUNCLE 17
901 GRANULOCYTOPENIA 17
902 HAIR DISORDER 17
903 LIPASE INCREASED 17
904 MANIA 17
905 MYOCARDIAL ISCHAEMIA 17
906 MYOSITIS 17
907 NEOPLASM PROGRESSION 17
908 NODULE 17
909 OPTIC NEURITIS 17
910 PHOTOSENSITIVITY REACTION 17
911 POISONING 17
912 PRODUCT LABEL ISSUE 17
913 PROTEINURIA 17
914 RED CELL DISTRIBUTION WIDTH INCREASED 17
915 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 17
916 SYSTEMIC LUPUS ERYTHEMATOSUS 17
917 THERAPEUTIC RESPONSE CHANGED 17
918 THERAPY CHANGE 17
919 VULVOVAGINAL PRURITUS 17
920 ABORTION SPONTANEOUS 16
921 BLOOD COUNT ABNORMAL 16
922 BLOOD PRESSURE DIASTOLIC DECREASED 16
923 BLOOD THYROID STIMULATING HORMONE INCREASED 16
924 BONE EROSION 16
925 BRAIN INJURY 16
926 BREAST CANCER FEMALE 16
927 CARDIAC MURMUR 16
928 COLON CANCER 16
929 CONJUNCTIVITIS 16
930 DIABETIC KETOACIDOSIS 16
931 DIVERTICULUM INTESTINAL 16
932 DRUG-INDUCED LIVER INJURY 16
933 EJECTION FRACTION DECREASED 16
934 ELECTROCARDIOGRAM ABNORMAL 16
935 EOSINOPHIL COUNT DECREASED 16
936 EYE MOVEMENT DISORDER 16
937 FAECES SOFT 16
938 GASTROINTESTINAL PAIN 16
939 HYPERTHERMIA 16
940 IMMUNE SYSTEM DISORDER 16
941 INCREASED TENDENCY TO BRUISE 16
942 INFUSION SITE PAIN 16
943 INTESTINAL ISCHAEMIA 16
944 KLEBSIELLA INFECTION 16
945 LUNG INFECTION 16
946 LYMPHOEDEMA 16
947 MENINGITIS 16
948 MONOCYTE COUNT INCREASED 16
949 MULTIPLE ALLERGIES 16
950 NEUROTOXICITY 16
951 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16
952 PROSTATOMEGALY 16
953 SKIN INFECTION 16
954 URINARY SEDIMENT PRESENT 16
955 ABNORMAL FAECES 15
956 APPENDICITIS 15
957 APPLICATION SITE SCAR 15
958 ASCITES 15
959 BLADDER CATHETERISATION 15
960 BLOOD CALCIUM INCREASED 15
961 COMPLICATION ASSOCIATED WITH DEVICE 15
962 DEFAECATION URGENCY 15
963 DROOLING 15
964 EXTRASYSTOLES 15
965 FIBULA FRACTURE 15
966 FULL BLOOD COUNT ABNORMAL 15
967 GINGIVAL PAIN 15
968 GLUCOSE TOLERANCE IMPAIRED 15
969 GYNAECOMASTIA 15
970 HAEMORRHAGE URINARY TRACT 15
971 HAEMORRHAGIC ANAEMIA 15
972 HAEMORRHAGIC STROKE 15
973 INJECTION SITE HAEMATOMA 15
974 INTERVERTEBRAL DISC DISORDER 15
975 MONOCYTE PERCENTAGE INCREASED 15
976 MULTI-ORGAN FAILURE 15
977 NO THERAPEUTIC RESPONSE 15
978 OLIGURIA 15
979 PHARYNGITIS STREPTOCOCCAL 15
980 POLYURIA 15
981 PRODUCT ODOUR ABNORMAL 15
982 PULMONARY THROMBOSIS 15
983 SECRETION DISCHARGE 15
984 SKIN INJURY 15
985 SPINAL COLUMN STENOSIS 15
986 SPUTUM DISCOLOURED 15
987 TONGUE DISORDER 15
988 TRIGGER FINGER 15
989 VITAMIN D DECREASED 15
990 ACIDOSIS 14
991 APPLICATION SITE HAEMORRHAGE 14
992 ARTHRITIS INFECTIVE 14
993 BLADDER DYSFUNCTION 14
994 BLOOD PRESSURE DIASTOLIC ABNORMAL 14
995 CATARACT OPERATION 14
996 CHAPPED LIPS 14
997 CYTOKINE RELEASE SYNDROME 14
998 DEVICE ADHESION ISSUE 14
999 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14